Nayman, A., Siginc, H., Zemheri, E., Yencilek, F., Yildirim, A. & Telci, D. (2019) Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo. JOURNAL OF CANCER , 10(6), 1466-1478.